CCSO | VO | CCSO / VO | |
Gain YTD | 3.517 | 3.669 | 96% |
Net Assets | 31.7M | 177B | 0% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 37.00 | 13.00 | 285% |
Yield | 0.81 | 1.50 | 54% |
Fund Existence | 2 years | 21 years | - |
CCSO | VO | |
---|---|---|
RSI ODDS (%) | 12 days ago88% | 12 days ago84% |
Stochastic ODDS (%) | 12 days ago90% | 12 days ago90% |
Momentum ODDS (%) | 12 days ago88% | 12 days ago80% |
MACD ODDS (%) | N/A | N/A |
TrendWeek ODDS (%) | 12 days ago88% | 12 days ago85% |
TrendMonth ODDS (%) | 12 days ago78% | 12 days ago79% |
Advances ODDS (%) | 14 days ago90% | 14 days ago84% |
Declines ODDS (%) | 12 days ago77% | 18 days ago79% |
BollingerBands ODDS (%) | N/A | N/A |
Aroon ODDS (%) | 12 days ago68% | 12 days ago84% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DVOL | 35.11 | 0.16 | +0.45% |
FirstTrustDorseyWrightMomt&LwVolatil ETF | |||
XMMO | 129.69 | 0.58 | +0.45% |
Invesco S&P MidCap Momentum ETF | |||
TPSC | 40.22 | 0.16 | +0.39% |
Timothy Plan US Small Cap Core ETF | |||
LGOV | 20.81 | 0.04 | +0.19% |
First Trust Long Duration Opp ETF | |||
CNCR | 11.67 | -0.03 | -0.26% |
Range Cancer Therapeutics ETF |
A.I.dvisor indicates that over the last year, CCSO has been closely correlated with BLDP. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if CCSO jumps, then BLDP could also see price increases.
Ticker / NAME | Correlation To CCSO | 1D Price Change % | ||
---|---|---|---|---|
CCSO | 100% | N/A | ||
BLDP - CCSO | 68% Closely correlated | -3.07% | ||
PLL - CCSO | 67% Closely correlated | -0.93% | ||
BLD - CCSO | 66% Closely correlated | +0.09% | ||
RUN - CCSO | 66% Loosely correlated | -1.15% | ||
MP - CCSO | 66% Loosely correlated | -1.09% | ||
More |